USER REVIEWS (mlgreen875)
Mentor Capital, INC (MNTR)
Chet Billingsley will not fund Breast Cancer Immunotherapy research or companies.
He has already been thrown out of one cancer immunotherapy company.
What little income Mentor Capital inc. (MNTR) (MNTR.PK) has is used to pay Chet's $104, 000 annual salary.
He might buy a few shares in some companies and then claim he has an "index" to measure his "investing" strategy.
Chet is peddling hope.
His only "income" is getting people to buy new stock in Mentor. read full review »
Mentor Capital, Inc. (MNTR.PK) (MNTR)
Mentor Capital owns no stock in Quantum Immunologics. Mentor, and itsw CEO, Chet Billingsley, agreed to a rescission. Last July 19, 2010, Chet cashed a check for $118, 000 from Quantum, thereby agreeing to the rescission, and returning Quantum stock to Quantum. As of today, Spet. 30, 2010, the MEntor Capital website seems to imply that Mentor still owns stock in Quantum. Chet Billingsly has not done a "Shareholders Update" on his website since may, 2010. The stockholders of Mentor Capital, Inc. (MNTR) (MNTR.PK) should know the truth about this very important matter. read full review »
|
RECENTLY UPDATED REVIEWS
McLaughlin Plumbing Heating & Cooling*
Consistently Professional and Dependable Service
Construction Lawyer Sydney
Whop
Bright Network LLC
The Green Recruitment Company
Orbit Dumpster Margate
Home Builder, General contractor, Home contractor
Casable | Broker Hipotecario Alcoy
dietitian in danville
REQUESTED REVIEWSREVIEWS BY CATEGORY |